THERANOVA Trademark

Trademark Overview


On Thursday, June 23, 2016, a trademark application was filed for THERANOVA with the United States Patent and Trademark Office. The USPTO has given the THERANOVA trademark a serial number of 87976728. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, October 23, 2024. This trademark is owned by Theranova LLC. The THERANOVA trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Business consulting services in the field of medical devices; Business consulting and management in the field of clinical trials concerning medical devices, namely, providing information management services; Business consulting services in the field of regulatory approvals concerning medical devices; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Business consulting services in the field of regulatory submissions concerning medical devices; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for medical device approval; Business consulting and management in the field of clinical trials concerning medical devices, namely, providing information management services...

Consulting services in the field of medical device product development; Consulting services, namely, product testing, product safety testing and product quality testing consultation in the field of experimental tests concerning medical devices; Consulting services regarding the conducting of clinical trials for others relating to medical devices in the field of physical pain, cardiovascular disease, diabetes, osteoporosis, [ dementia, ] incontinence, overactive bladder, vascular access, body fluid drainage, and enteral feeding and monitoring; New product design, engineering, research, development services for others in the field of medical devices; in each case, except in the field of dialysis
theranova

General Information


Serial Number87976728
Word MarkTHERANOVA
Filing DateThursday, June 23, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, October 23, 2024
Registration Number5420042
Registration DateTuesday, March 6, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2017

Trademark Statements


Pseudo MarkTHERA NOVA
Goods and ServicesBusiness consulting services in the field of medical devices; Business consulting and management in the field of clinical trials concerning medical devices, namely, providing information management services; Business consulting services in the field of regulatory approvals concerning medical devices; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Business consulting services in the field of regulatory submissions concerning medical devices; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for medical device approval; Business consulting and management in the field of clinical trials concerning medical devices, namely, providing information management services; Business consulting services in the field of quality system information management concerning medical devices; Regulatory submission management, namely, assisting others in preparing and filing applications for medical devices with governmental regulatory bodies; in each case, except in connection with dialysis
Goods and ServicesConsulting services in the field of medical device product development; Consulting services, namely, product testing, product safety testing and product quality testing consultation in the field of experimental tests concerning medical devices; Consulting services regarding the conducting of clinical trials for others relating to medical devices in the field of physical pain, cardiovascular disease, diabetes, osteoporosis, [ dementia, ] incontinence, overactive bladder, vascular access, body fluid drainage, and enteral feeding and monitoring; New product design, engineering, research, development services for others in the field of medical devices; in each case, except in the field of dialysis

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, June 29, 2016
Primary Code035
First Use Anywhere DateSaturday, December 31, 2005
First Use In Commerce DateSaturday, December 31, 2005

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 29, 2016
Primary Code042
First Use Anywhere DateSaturday, December 31, 2005
First Use In Commerce DateSaturday, December 31, 2005

Trademark Owner History


Party NameTheranova LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSan Francisco, CA 94107

Party NameTheranova LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Francisco, CA 94107

Party NameTheranova LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Francisco, CA 94107

Trademark Events


Event DateEvent Description
Thursday, June 30, 2016NOTICE OF PSEUDO MARK E-MAILED
Monday, June 27, 2016NEW APPLICATION ENTERED
Wednesday, June 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 29, 2016ASSIGNED TO EXAMINER
Thursday, October 6, 2016NON-FINAL ACTION WRITTEN
Thursday, October 6, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 6, 2016NON-FINAL ACTION E-MAILED
Monday, January 9, 2017ASSIGNED TO EXAMINER
Monday, February 27, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 27, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 29, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 25, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 17, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2017PUBLISHED FOR OPPOSITION
Tuesday, June 6, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 1, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 17, 2018USE AMENDMENT FILED
Wednesday, January 17, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, January 17, 2018TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, January 17, 2018DIVISIONAL REQUEST RECEIVED
Monday, January 29, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 30, 2018DIVISIONAL PROCESSING COMPLETE
Tuesday, January 30, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 30, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 31, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, November 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 29, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, March 6, 2018REGISTERED-PRINCIPAL REGISTER
Monday, March 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 23, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 23, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, October 23, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED